Who We Are
OneMore is an initiative of the Translational Genomics Research Institute (TGen) that embraces a comprehensive approach to help pancreatic cancer patients in the near-term and ultimately put an end to this devastating disease.
Using the most advanced tools and technologies available, TGen is determined to develop revolutionary advances in treating and defeating this cancer though a better understanding of the underlying genetic causes of the disease.